Noesis Capital Mangement’s iShares Biotechnology ETF IBB Stock Holding History

Noesis Capital Mangement’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,230	Closed	-$215K	–	87
2018 Q4	$215K	Hold	2,230	–	–	0.09%	83
2018 Q3	$272K	Hold	2,230	–	–	0.1%	75
2018 Q2	$245K	Hold	2,230	–	–	0.09%	84
2018 Q1	$238K	Buy	2,230 +55	+3%	+$6.1K	0.09%	86
2017 Q4	$232K	Hold	2,175	–	–	0.08%	89
2017 Q3	$242K	Hold	2,175	–	–	0.09%	85
2017 Q2	$225K	Hold	2,175	–	–	0.09%	92
2017 Q1	$213K	Buy	+2,175	New	+$208K	0.08%	96
2016 Q4	–	Sell	-2,175	Closed	-$210K	–	91
2016 Q3	$210K	Buy	+2,175	New	+$207K	0.09%	81
2015 Q3	–	Sell	-8,772	Closed	-$1.08M	–	92
2015 Q2	$1.08M	Buy	8,772 +474	+6%	+$56.7K	0.47%	43
2015 Q1	$950K	Sell	8,298 -4,245	-34%	-$468K	0.39%	53
2014 Q4	$1.27M	Buy	12,543 +39	+0.3%	+$3.79K	0.53%	40
2014 Q3	$1.14M	Sell	12,504 -4,551	-27%	-$399K	0.5%	43
2014 Q2	$1.46M	Sell	17,055 -2,493	-13%	-$196K	0.66%	34
2014 Q1	$1.54M	Buy	19,548 +531	+3%	+$44.2K	0.76%	31
2013 Q4	$1.44M	Buy	19,017 +1,377	+8%	+$97.7K	0.71%	34
2013 Q3	$1.23M	Sell	17,640 -870	-5%	-$57K	0.65%	44
2013 Q2	$1.07M	Buy	+18,510	New	+$1.07M	0.57%	50

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Noesis Capital Mangement's IBB Position: Q1 2019 in Review

Noesis Capital Mangement sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 2,230 shares — an estimated $215K sold.

Noesis Capital Mangement first reported a position in IBB in Q2 2013 and held it in 18 quarters. The position peaked at $1.54M in Q1 2014. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Noesis Capital Mangement reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
Noesis Capital Mangement sold 2,230 iShares Biotechnology ETF shares in Q1 2019, an estimated $215K.
Noesis Capital Mangement first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 18 quarters.
Noesis Capital Mangement's iShares Biotechnology ETF position peaked at $1.54M in Q1 2014.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Noesis Capital Mangement's 13F filing for Q1 2019, filed 9 May 2019.